Pharmaceutical Chemistry Journal

, Volume 34, Issue 1, pp 1–7 | Cite as

Adamantane derivatives: Pharmacological and toxicological properties (review)

  • A. A. Spasov
  • T. V. Khamidova
  • L. I. Bugaeva
  • I. S. Morozov
Molecular-biological Problems of Drug Design and Mechanism of Drug Action

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    I. E. Kovalev, L. I. Durakova, M. I. Shmar'yan, et al.,Khim. -Farm. Zh.,11(20), 3–7 (1977).Google Scholar
  2. 2.
    Yu. N. Klimochkin, I. K. Moiseev, G. V. Vadyko, et al.,Khim. -Farm. Zh.,25(7), 46–49 (1991).Google Scholar
  3. 3.
    M. D. Mashkovskii,Drugs [in Russian], Meditsina, Moscow (1993), pp. 176–177.Google Scholar
  4. 4.
    Z. E. Stolyarov, A. G. Fedorchuk, and L. A. Prishchepa,Khim. -Farm. Zh.,27(9), 4–8 (1993).Google Scholar
  5. 5.
    I. M. Kamyanov and R. A. Andrezinya,Eksp. Klin. Farmakoterap. (Zinatne), No. 9, 105–110 (1980).Google Scholar
  6. 6.
    J. Kornhuber, M. Weller, K. Schoppmeyer, et al.,J. Neural. Transm. Suppl.,43, 91–104 (1994).PubMedGoogle Scholar
  7. 7.
    W. H. Oertel and R. C. Dodel,Mov. Disord.,10(2), 121–131(1995).PubMedCrossRefGoogle Scholar
  8. 8.
    I. G. Kharitonenko, S. el Karadagi, A. N. Fedorov et al.,Vopr. Virusol.,33(1), 22–26 (1988).Google Scholar
  9. 9.
    V. A. Tverdislov, S. el Karadagi, I. G. Kharitonenkov, et al.,Gen. Physiol. Biophys.,5(1), 61–75 (1986).PubMedGoogle Scholar
  10. 10.
    O. I. Kiselev, V. M. Blinov, K. N. Kozeletskaya, et al.,Vestn. Ross. Akad. Med. Nauk, No. 3, 10–15 (1993).PubMedGoogle Scholar
  11. 11.
    Z. E. Stolyarov and K. P. Lyashchenko,Khim. -Farm. Zh.,29(8), 9–10 (1995).Google Scholar
  12. 12.
    C. Clark, M. M. Woodson, N. T. Nagasava,Immunopharmacology,21(1), 40–50 (1991).CrossRefGoogle Scholar
  13. 13.
    A. V. Val'dman, M. M. Kozlovskaya, and S. K. Germane,Eksp. Klin. Farmakoterap. (Zinatne), No. 8, 142–154 (1979).Google Scholar
  14. 14.
    A. M. Zharkovskii,Farmakol. Toksikol., No. 5, 517–521 (1977).Google Scholar
  15. 15.
    A. M. Zharkovskii, S. Ya. Mark, and L. Kh. Allikmets,Proc. Meet. on Current Problems in Neuropharmacology [in Russian], Tartu (1973), pp. 53–56.Google Scholar
  16. 16.
    G. W. VollerDt. Med. Wovh. -Shcr.,95(17), 934 (1974).Google Scholar
  17. 17.
    L. Kh. Allikmets and A. A. Ross,Proc. Meet. on the Current Problems in Neuropharmacology [in Russian], Tartu (1973), pp. 92–96.Google Scholar
  18. 18.
    A. M. Zharkovskii, S. Ya. Mark, and L. Kh. Allikmets, in:Problems in the Pharmacology of Neurotropic Drugs [in Russian], Zinatne, Riga (1974), pp. 43–46.Google Scholar
  19. 19.
    S. V. Krapivin, S. A. Sergeeva, I. S. Morozov, et al.,Byul. Eksp. Biol. Med., No. 7, 57–59 (1991).Google Scholar
  20. 20.
    M. Weller, F. Finiels Marlier, and S. M. Paul,Brain. Res.,613(1), 143–148 (1993).PubMedCrossRefGoogle Scholar
  21. 21.
    J. Kornhuber, K. Schoppmeyer, and R. Riederer,Neurosci. Lett.,163(2), 129–131 (1993).PubMedCrossRefGoogle Scholar
  22. 22.
    I. Bresink, W. Danysz, C. G. Parsons, et al.,Neuropharmacology,34(5), 533–540 (1995).PubMedCrossRefGoogle Scholar
  23. 23.
    V. Kunzelmann,Fortschr. Med.,111(27), 423–425 (1993).PubMedGoogle Scholar
  24. 24.
    M. G. Garrino and J. C. Henquin,Br. J. Pharmacol.,90(3), 583–591 (1987).PubMedGoogle Scholar
  25. 25.
    N. F. Pravdina, S. G. Tul'kes, V. M. Shobukhov, et al.,Vopr. Virusol., No. 2, 208–209 (1982).Google Scholar
  26. 26.
    C. Koppel and J. Tenczer,Biomed. Mass. Spectrom.,12(9), 499–501 (1985).PubMedCrossRefGoogle Scholar
  27. 27.
    S. A. Sergeeva and L. M. KrasnykhEksp. Klin. Farmakol.,57(3), 69–74 (1994).PubMedGoogle Scholar
  28. 28.
    M. M. Zhiravetskii, N. A. Leont'eva, I. A. Vinograd, et al.,Vopr. Med. Khim.,32(6), 118–120 (1986).PubMedGoogle Scholar
  29. 29.
    G. A. Galegov and V. M. Zhukov,Vestn. Akad. Med. Nauk SSSR, No. 3, 77–81 (1976).PubMedGoogle Scholar
  30. 30.
    F. G. Hayden, A. Minocha, D. A. Spyker, et al.,Antimicrob. Agents Chemother.,28(2), 216–221 (1985).PubMedGoogle Scholar
  31. 31.
    R. L. Tominack and F. G. Hayden,Infect. Dis. Clin. North. Am.,1(2), 459–478 (1987).PubMedGoogle Scholar
  32. 32.
    E. Donath, A. Herrmann, W. T. Coakley, et al.,Biochem. Pharmacol.,36(4), 481–487 (1987).PubMedCrossRefGoogle Scholar
  33. 33.
    S. K. Germane,Eksp. Klin. Farmakoterap. (Zinatne), No. 15, 6–13 (1986).Google Scholar
  34. 34.
    S. V. Krapivin and I. S. Morozov,Eksp. Klin. Farmakol.,57(5), 66–72 (1994).PubMedGoogle Scholar
  35. 35.
    R. A. Andrezinya,Author's Abstract of Cand. Sci. (Med. Sci.) Thesis [in Russian], Tartu (1973), pp. 92–96.Google Scholar
  36. 36.
    R. O. Vitalin' and A. A. Kimenis,Eksp. Klin. Farmakoterap. (Zinatne), No. 9, 99–104 (1980).Google Scholar
  37. 37.
    S. K. Germane, M. M. Krima, D. A. Berzinya, et al.,Directed Search for New Neurotropic Preparations [in Russian], Zinatne Riga (1983), pp. 42–59.Google Scholar
  38. 38.
    H. S. Chen, J. W. Pellegrini, S. K. Aggarwal, et al.,J. Neurosci.,12(11), 4427–4436 (1992).PubMedGoogle Scholar
  39. 39.
    J. M. Rabey, P. Nissipeanu, A. D. Korczyn,J. Neural. Transm. Park. Dis. Dement. Sect., No. 4, 277–282 (1992).PubMedCrossRefGoogle Scholar
  40. 40.
    E. Eisenberg, B. P. Vos, A. M. Strassman,Pain 54(3), 301–307 (1993).PubMedCrossRefGoogle Scholar
  41. 41.
    K. Masuo, R. Enomoto, N. Maeno,Eur. J. Pharmacol.,130(3), 187–195 (1986).PubMedCrossRefGoogle Scholar
  42. 42.
    I. S. Morozov, V. G. Barchukov, N. P. Bykov, et al.,Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacologists (9–13 October, 1995) [in Russian], Moscow (1995), p. 291.Google Scholar
  43. 43.
    I. S. Morozov, N. V. Klimova, N. I. Avdyunina, et al.,Abstracts of Papers. The 7th Sci. -Pract. Conf. of CIS Countries “Prospects in Development of the Chemistry and Applications of Framework Compounds” (5–7 September, 1995) [in Russian], Volgograd (1995), p. 166–167.Google Scholar
  44. 44.
    S. A. Sergeeva, V. V. Khoron'ko, L. M. Krasnykh, et al.,Abstracts of Papers. The 1st Meet. All-Russia Sci. Soc. Pharmacologists (9–13 October, 1995) [in Russian], Moscow (1995), p. 389.Google Scholar
  45. 45.
    T. V. Grekhova, R. R. Gainetdinov, T. D. Sotnikova, et al.,Byul. Eksp. Biol. Med., No. 3, 302–304 (1995).Google Scholar
  46. 46.
    A. A. Spasov, L. I. Bugaeva, I. N. Yozhitsa, et al.,Farmakoterapiya,1/2(3), 86 (1997).Google Scholar
  47. 47.
    S. V. Krapivin, S. A. Sergeeva, I. S. Morozov,Byul. Eksp. Biol. Med.,116(11), 515–518 (1993).Google Scholar
  48. 48.
    T. S. Galushkina, T. A. Fadeeva, and N. G. Artsimovich,Immunologiya, No. 4, 28–30 (1996).Google Scholar
  49. 49.
    L. M. Krasnykh and S. A. Sergeeva,Abstracts of Papers. The 7th Sci. -Pract. Conf. of CIS Countries “Prospects in Development of the Chemistry and Applications of Framework Compounds” (5–7 September, 1995) [in Russian], Volgograd (1995), pp. 170–171.Google Scholar
  50. 50.
    S. A. Sergeeva and L. M. Krasnykh,Khim. -Farm. Zh.,29(4), 28–29 (1995).Google Scholar
  51. 51.
    N. G. Artsimovich, T. A. Fadeeva, Yu. A. Shalyminova, USSR Inventor's Certificate No. 1 586 711;Byul. Izobret., No. 31 (1990).Google Scholar
  52. 52.
    E. M. Rekalova,Vrach. Delo, No. 4, 73–76 (1992).Google Scholar
  53. 53.
    V. M. Man'ko, B. V. Pinegin, T. V. Rudneva, et al.,Zh. Mikrobiol., Epidemiol. Immunobiol., No. 9, 66–67 (1991).Google Scholar
  54. 54.
    V. M. Man'ko, B. V. Pinegin, T. V. Rudneva, et al.,Zh. Mikrobiol., Epidemiol. Immunobiol., No. 9, 6–65 (1991).Google Scholar
  55. 55.
    S. S. Boiko, V. P. Zherdev, and N. A. Kislyak,Farmakol. Toksikol., No. 1, 57–60 (1991).Google Scholar
  56. 56.
    S. S. Boiko, V. P. Zherdev, and N. A. Kislyak,Khim. -Farm. Zh.,25(1), 76–78 (1991).Google Scholar
  57. 57.
    S. S. Boiko, V. P. Zherdev, N. A. Kislyak, et al.,Eksp. Klin. Farmakol.,57(6), 48–50 (1994).PubMedGoogle Scholar
  58. 58.
    V. P. Zherdev, S. S. Boiko, N. A. Kislyak, et al.,Khim. -Farm. Zh.,29(1), 32–34 (1995).Google Scholar
  59. 59.
    D. A. Kharkevich,Farmakol. Toksikol. No. 5, 531–536 (1970).Google Scholar
  60. 60.
    E. P. Svadzhan and V. V. Shitov,Eksp. Khir., No. 6, 62–66 (1975).Google Scholar
  61. 61.
    V. A. Mikel'son, L. E. Tsypin, A. P. Makarov, et al.,Vestn. Akad. Med. Nauk SSSR, No. 2, 77–80 (1977).Google Scholar
  62. 62.
    V. Yu. Ostrovskii and S. D. Kiselev,Anesteziol. Revmatol., No. 3, 7–10 (1080).Google Scholar
  63. 63.
    V. P. Fisenko,Author's Abstract of Cand. Sci. (Med. Sci.) Thesis [in Russian], Moscow (1971), p. 14.Google Scholar
  64. 64.
    D. A. Kharkevich and A. P. Skoldinov,Dokl. Akad. Nauk SSSR,198(4), 984–987 (1971).Google Scholar
  65. 65.
    E. N. Pershin,Farmakol. Toksikol., No. 5, 517–527 (1975).Google Scholar
  66. 66.
    M. K. Indulen, I. A. Kenal', G. M. Ryazantseva, et al.,Izv. Akad. Nauk LatSSR, No. 9, 88–97 (1972).Google Scholar
  67. 67.
    G. Fytas, P. Marakos, N. Kolocouris, et al.,Farmaco,49(10), 641–647 (1994).PubMedGoogle Scholar
  68. 68.
    G. I. Danilenko, V. I. Votyakov, O. T. Andreeva, et al.,Khim. -Farm. Zh.,11(5), 71–73 (1977).Google Scholar
  69. 69.
    S. G. Markushin, B. V. Sinitsyn, V. P. Ginzburg, et al.,Vopr. Virusol.,38(3), 122–126 (1993).PubMedGoogle Scholar
  70. 70.
    L. L. Stotskaya, A. V. Serbin, K. Munshi, et al.,Khim. -Farm. Zh.,29(3), 19–22 (1995).Google Scholar
  71. 71.
    A. Papadaki Valiraki, S. Papakonstantinou Garoufalias, P. Marakos, et al.,Farmacol.,48(8), 1091–1102 (1993).Google Scholar
  72. 72.
    I. A. Novakov, V. P. Petrov, B. S. Orlinson, et al.,Khim. -Farm. Zh.,30(2), 22–24 (1996).Google Scholar
  73. 73.
    S. K. Germane, Ya. Yu. Polis, and L. Ya. Karinya,Khim. -Farm. Zh.,11(3), 66–70 (1977).Google Scholar
  74. 74.
    L. G. Magazinik, S. M. Antonov, N. Ya. Lukomskaya, et al.,Fiziol. Zh. im. I. M. Sechenova,80(7), 99–112 (1994).Google Scholar
  75. 75.
    S. M. Antonov, J. W. Johnson, and N. Y. Lukomskaya,Mol. Pharmacol.,47(3), 558–567 (1995).PubMedGoogle Scholar
  76. 76.
    E. Acquas, J. C. Day, and H. C. Fibiger,Eur. J. Pharmacol.,260(1), 85–87 (1994).PubMedCrossRefGoogle Scholar
  77. 77.
    N. Pouli, G. Fytas, G. B. Foscolos, et al.,Ann. Pharm. Fr.,53(4), 163–169 (1995).PubMedGoogle Scholar
  78. 78.
    V. V. Buyanov,Farmakol. Toksikol.,50(6), 37–41 (1987).Google Scholar
  79. 79.
    S. Kondo, T. Morita, and S. Hirano,J. Smooth. Muscle. Res.,29(2), 63–68 (1993).PubMedGoogle Scholar
  80. 80.
    E. E. Nattie, A. Li, J. Mills, et al.,Respir. Physiol,96(2–3), 189–197 (1994).PubMedCrossRefGoogle Scholar
  81. 81.
    J. W. Kebabian, D. R. Britton, M. P. DeNinno, et al.,Eur. J. Pharmacol.,229(2–3), 203–209 (1992).PubMedCrossRefGoogle Scholar
  82. 82.
    K. E. Asin and D. Wirtshafter,Eur. J. Pharmacol.,235(1), 167–168 (1993).PubMedCrossRefGoogle Scholar
  83. 83.
    R. Ranaldi and R. J. Beninger,Brain-Res.,651(1–2), 283–292 (1994).PubMedCrossRefGoogle Scholar
  84. 84.
    N. Y. Huang and R. M. Kostrzewa,Eur. J. Pharmacol.,253(1–2), 163–166 (1994).PubMedGoogle Scholar
  85. 85.
    S. Ofori, S. De Raad, O. Bugnon, et al.,Gen. Pharmacol.,26(1), 51–57 (1995).PubMedGoogle Scholar
  86. 86.
    M. Azzi, D. Gully, M. Heaulme, et al.,Eur. J. Pharmacol.,255(1–3), 167–174 (1994).PubMedCrossRefGoogle Scholar
  87. 87.
    O. Valverde, R. Maldonado, M. C. Fournie Zaluski, et al.,J. Pharmacol. Exp. Ther.,270(1), 77–88 (1994).PubMedGoogle Scholar
  88. 88.
    N. I. Avdyunina, N. V. Klimova, A. S. Lebedeva, et al.,Khim. -Farm. Zh.,29(2), 34–36 (1995).Google Scholar
  89. 89.
    C. S. Chang and S. S. Liao,J. Steroid. Biochem.,27(1–3), 123–131 (1987).PubMedCrossRefGoogle Scholar
  90. 90.
    K. E. Gerson, E. V. Krumkalns, R. L. Brindle, et al.,J. Med. Chem., No. 6, 760 (1963).CrossRefGoogle Scholar
  91. 91.
    Ts. E. Agadzhanyan, D. D. Arutyunyan, N. O. Stepanyan,Khim. -Farm. Zh.,31(1), 17–18 (1997).Google Scholar
  92. 92.
    H. T. Nagasawa, Y. Yost, J. A. Elberling, et al.,Biochem. Pharmacol.,45(10), 2129–2134 (1993).PubMedCrossRefGoogle Scholar
  93. 93.
    A. J. Kennedy, A. Cline, U. M. Ney, et al.,Eur. J. Respir. Dis.,71(5), 472–478 (1987).PubMedGoogle Scholar
  94. 94.
    D. E. Sakas, R. M. Crowell, K. Kim, et al.,Stroke,25(1), 197–201 (1994).PubMedGoogle Scholar
  95. 95.
    D. E. Sakas, R. M. Crowell and N. T. Zervas,Artif. Cells. Blood. Substit. Immobil. Biotechnol.,22(1), 83–89 (1994).PubMedGoogle Scholar
  96. 96.
    K. D. Meisheri, S. J. Humphrey, S. A. Khan, et al.,J. Pharmacol. Exp. Ther.,266(2), 655–665 (1993).PubMedGoogle Scholar
  97. 97.
    C. E. Ohrnberger, S. A. Khan, and K. D. Meisheri,J. Pharmacol. Exp. Ther.,267(1), 25–30 (1993).PubMedGoogle Scholar
  98. 98.
    S. C. Perricone, S. J. Humphrey, L. L. Skaletzky, et al.,J. Med. Chem.,37(22), 3693–3700 (1994).PubMedCrossRefGoogle Scholar
  99. 99.
    M. P. Smith, S. J. Humphrey, and W. F. Jackson,Pharmacology,49(6), 363–375 (1994).PubMedCrossRefGoogle Scholar
  100. 100.
    K. Meisheri, M. Fosset, S. Humphrey, et al.,Mol. Pharmacol.,47(1), 155–163 (1995).PubMedGoogle Scholar
  101. 101.
    I. E. Kovalev, L. I. Durakova, M. I. Shmar'yan, et al.,Khim. -Farm. Zh.,11(2), 3–7 (1977).Google Scholar
  102. 102.
    G. L. Arutyunyan, A. A. Chachoyan, and Ts. E. Agadzhanyan,Khim. -Farm. Zh.,30(12), 20–21 (1996).Google Scholar
  103. 103.
    G. L. Arutyunyan, A. A. Chachoyan, V. A. Shkulev, et al.,Khim. -Farm. Zh.,29(3), 33–35 (1995).Google Scholar
  104. 104.
    V. A. Shkulev, G. G. Adamyan, Ts. E. Agadzhanyan, et al.,Khim. -Farm. Zh.,29(3), 36–37 (1995).Google Scholar
  105. 105.
    L. N. Lavrova, A. M. Vasil'ev, V. S. Korytnyi, et al.,Khim. -Farm. Zh.,27(3), 38–40 (1993).Google Scholar
  106. 106.
    L. N. Lavrova, I. P. Savchanko, D. M. Vasil'ev, et al.,Khim. -Farm. Zh.,27(8), 40–43 (1993).Google Scholar
  107. 107.
    A. Banerjee, C. Roman, and M. A. Heymann,Pediatr. Res.,36(4), 474–480 (1994).PubMedGoogle Scholar
  108. 108.
    C. E. Austin and J. C. Foreman,J. Physiol. Lond.,478(Pt 2), 351–356 (1994).PubMedGoogle Scholar
  109. 109.
    F. Suzuki, J. Shimada, H. Nonaka, et al.,J. Med. Chem.,35(19), 3578–3581 (1992).PubMedCrossRefGoogle Scholar
  110. 110.
    A. E. Davey and D. C. Horwell,Bioorg. Med. Chem.,1(1), 45–58 (1993).PubMedCrossRefGoogle Scholar
  111. 111.
    A. G. Blommaert, J. H. Weng, A. Dorville, et al.,J. Med. Chem.,36(20), 2868–2877 (1993).PubMedCrossRefGoogle Scholar
  112. 112.
    V. Ya. Parinov, M. D. Ktrieva, and Ya. Yu. Polis,Eksp. Klin. Farmakoterap. (Zinatne), No. 15, 60–64 (1986).Google Scholar
  113. 113.
    Centers for Disease Control. Prevention and Control of Influenza: Recommendations of Immunization Practices Advisory Committee (ACIP).MMWR 41 (Suppl RR-9), 1–17 (1992).Google Scholar
  114. 114.
    Anon. Influenza Prevention, 1987–1988,Med. Lett., Drugs Ther.,29, 81–82 (1987).Google Scholar
  115. 115.
    Symmetrel (Amantadine Hydrochloride) Prescribing Information, Barnhart E. R., publisher.Physicians Desk Reference, 44th ed., Oradell, Medical Economics Company, 929–930 (1990).Google Scholar
  116. 116.
    Yu. B. Belousov, V. S. Moiseev, and V. K. Lepakhin,Clinical Pharmacology and Pharmacotherapy [in Russian], Universum Publ., Moscow (1997), pp. 345, 493.Google Scholar
  117. 117.
    V. A. Aleksandrov, K. M. Pozharisskii, A. Ya. Likhachev, et al.,Vopr. Onkol.,8(9), 23–28 (1982).Google Scholar
  118. 118.
    M. C. Nahata and M. T. Brady,Eur. J. Clin. Pharmacol.,30(6), 719–722 (1986).PubMedCrossRefGoogle Scholar
  119. 119.
    E. L. Anderson, L. P. Van Voris, J. Bartram, et al.,Antimicrob. Agents Chemother.,31(7), 1140–1142 (1987).PubMedGoogle Scholar
  120. 120.
    L. I. Bugaeva, G. P. Dudchenko, L. S. Mazanova, et al.,Abstracts of Papers.The 2nd All-Russia Congr. “Humans and Drugs” [in Russian], Farmedinfo, Moscow (1995), p. 48.Google Scholar
  121. 121.
    T. V. Khamidova, A. A. Spasov, L. I. Bugaeva, et al.,J. Physiol. Biochem. (Rev. Esp. Fisiol.),53(1), 152 (1997).Google Scholar
  122. 122.
    T. V. Khamidova, A. A. Spasov, L. I. Bugaeva, et al.,Abstracts of 11th Noordwijkerhout- Camerino Symposium “Trends in Drug Research” 11–15 May, Noordwijkerhout, the Netherlands (1997a), p. 65.Google Scholar
  123. 123.
    I. N. Yozhitsa, A. A. Sparov, L. I. Bugaeva, et al.,J. Physiol. Biochem. (Rev. Esp. Fisiol.),53(1), 153 (1997).Google Scholar
  124. 124.
    N. V. Korobov and A. N. Yavorskii,Farmakol. Toksikol.,44(3), 338–342 (1981).PubMedGoogle Scholar
  125. 125.
    P. J. Creaven, S. F. Zakrzewski, W. R. Greco, et al.,Cancer. Chemother. Pharmacol., No. 2, 122–128 (1988).Google Scholar

Copyright information

© Kluwer Academic/Plenumm Publishers 2000

Authors and Affiliations

  • A. A. Spasov
    • 1
  • T. V. Khamidova
    • 1
  • L. I. Bugaeva
    • 1
  • I. S. Morozov
    • 2
  1. 1.Institute of PharmacologyState Medical AcademyVolgogradRussia
  2. 2.Institute of PharmacologyRussian Academy of Medical SciencesMoscowRussia

Personalised recommendations